Berotralstat Prophylaxis Reduces News Today : Breaking News, Live Updates & Top Stories | Vimarsana

These new data from BioCryst, presented at AAAAI, suggest that patients treated with berotralstat may see substantial decreases in HAE attacks.

United statesJonathan bernsteinA prospective survey in community pharmaciesBernstein allergy group jonathanUniversity of cincinnatiBiocryst pharmaceuticals incAmerican academy of allergyBernstein allergy groupCryst pharmaceuticalsBerotralstat prophylaxis reducesRates regardlessBaseline attacksReal world outcomesBerotralstat regardlessPrior prophylaxisReal world effectiveness